undefined
Exports
$3.9BWorld Rnk 15 / 208
FlagN/A
falsefalse United States
N/A
PRODUCT COMPLEXITY IN Vaccines, blood, antisera, toxins and cultures
1.38Rnk 75 / 1025

About

Exports In N/A, Japan exported $3.9B in Vaccines, blood, antisera, toxins and cultures, making it the 15th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the N/A most exported product in Japan. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Japan are: United States ($1.53B), Switzerland ($1.17B), Germany ($257M), United Kingdom ($157M), and South Korea ($128M).

Imports In N/A, Japan imported $19.6B in Vaccines, blood, antisera, toxins and cultures, becoming the N/A largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the N/A most imported product in Japan. Japan imports Vaccines, blood, antisera, toxins and cultures primarily from: N/A.

Historical Data

Trade Balance

Color
EXPORTS (2022)$3.9B
IMPORTS (2022)$19.6B
NET TRADE (2022)-$15.7B

In 2022, Japan exported $3.9B in Vaccines, blood, antisera, toxins and cultures. The main destinations of Japan exports on Vaccines, blood, antisera, toxins and cultures were United States ($1.53B), Switzerland ($1.17B), Germany ($257M), United Kingdom ($157M), and South Korea ($128M).

Explore Visualizations

Market Growth

Flow

Market Concentration

View
Flow
Type
In N/A, Japan's main exporting competitors in Vaccines, blood, antisera, toxins and cultures were:
Ireland $47.3B
Belgium $47.1B
Belgium $46.8B

Explore Visualizations

Potential Exports

Potential Exports

Flow
View
TOP EXPORT POTENTIALGermany+ $192M
TOP IMPORT POTENTIALGermany+ $401M

Vaccines, blood, antisera, toxins and cultures’s highest export potential is Germany. With an export gap of $192M.   Vaccines, blood, antisera, toxins and cultures’s highest import potential is Germany with an import gap of $401M.

See methodology.

Subscribe today to OEC pro and access the latest data

Sign Up

Have questions, comments, or concerns?
Send us an e-mail: support@oec.world
Follow @OECtoday on
Created, Designed, and Developed by:
In collaboration with